Related Experiment Video
Updated: Oct 27, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome
Fereshteh Ashtari1, Rasool Soltani2, Shervin Shokouhi3,4
1Isfahan Neuroscience Research Center Isfahan University of Medical Sciences Isfahan Iran.
Abstract:
Methylprednisolone pulse therapy has significant anti-inflammatory effects in multiple sclerosis. Acute respiratory distress syndrome as a probable adverse effect of methylprednisolone pulse therapy in MS patients should be considered.
Insights
Methylprednisolone pulse therapy effectively reduces inflammation in multiple sclerosis (MS). However, acute respiratory distress syndrome is a potential adverse effect that warrants consideration in MS patients.
Area of Science:
- Neurology
- Immunology
- Pulmonology
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Methylprednisolone pulse therapy is a common treatment for MS exacerbations due to its anti-inflammatory properties.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV
Acute Respiratory Failure-III
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Pulmonary Cycle: Exhalation
Allergic Reactions

